The S&P 500's median year-end target is 5,900 among 17 Wall Street institutions, which implies little change from its current level in the remaining months of 2025. However, the duties imposed by ...

On the winning end of Wall Street was Novavax, which rose 15% after it said U.S. regulators approved its COVID-19 vaccine under some conditions. The approval triggered a $175 million milestone payment ...

On the winning end of Wall Street was Novavax, which rose 15% after it said U.S. regulators approved its COVID-19 vaccine under some conditions. The approval triggered a $175 million milestone ...

Australia's S&P/ASX 200 declined 0.1% to 8,333.80. Taiwan's Taiex was 0.8% lower. Wall Street cruised to a strong finish last week as U.S. stocks glided closer to the all-time high they set just a ...